Gevo has appointed K’Lynne Johnson, a veteran executive in renewable chemicals and industrial businesses, to its board. The appointment takes effect November 4, adding an independent director with experience in technology commercialization, manufacturing and corporate transformation.
- Johnson will serve as a Class II director, with her current term running through Gevo’s 2027 annual shareholder meeting.
- Her director compensation includes an annual cash retainer of $85,000 and an equity award valued at $63,000. She will also be eligible for future annual equity grants and other compensation under the company’s director compensation policy.
- Gevo’s board determined that Johnson meets Nasdaq’s independence standards.
- Johnson founded and formerly led Elevance Renewable Sciences, which developed and commercialized technology using biobased feedstocks to produce alternatives to conventional petrochemicals and oleochemicals. Earlier in her career, she held senior roles at BP and Amoco.
- She currently serves on the boards of FMC Corporation, Trinseo, J.M. Huber Corporation and BlueScope Steel, and is independent board chair of DMC Biotechnologies.
- Gevo said Johnson’s experience will support its next phase of growth and value creation. Johnson said she plans to work with the board and management as the company develops its businesses and pursues its strategy.
The change is a board addition, not an announced shift in executive leadership or company control. Johnson’s appointment brings renewable-technology and industrial operating experience to the board; the company did not announce other governance changes.